“…Various treatments have been evaluated and recommended to improve skin flap survival, especially when long flaps are needed to cover large defects (1,2,5). Cer-tain growth factors implicated in neovascularisation, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-β), have demonstrated ability to improve the microcirculation and thus the viability of a skin flap (5,6,(8)(9)(10)(11). It has been suggested that the combined use of growth factors may be more effective than the use of a single growth factor for improving wound healing (12,13).…”